![Dr. Kanan Al Shammari](https://international-clinicaltrials.kaimrc.ksau-hs.edu.sa/wp-content/uploads/2024/01/Dr.-Kanan-Al-Shammari-e1707380768929-390x390.jpg)
Dr. Kanan Al Shammari
Dr. Kanan Alshammari is a consultant of adult medical oncology at King Abdulaziz Medical City – Ministry of National Guard for Health Affairs (MNGHA) in Riyadh, Saudi Arabia, and an Assistant Professor at the College of Medicine of King Saud bin Abdulaziz University (KSAU) for Health Sciences. He is also the director of the NCCN MENA regional coordinating center at MNGHA. He finished his undergraduate training at the University of Otago in New Zealand obtaining his MBChB in 2008. He then obtained the Saudi Board of Internal Medicine in 2014. He did his medical oncology training at McMaster University in Hamilton, Canada, and obtained the Royal College of Physicians and Surgeons of Canada Subspecialty Affiliate certification in 2018. He then did another fellowship in drug development/phase 1 oncology trials and sarcoma in 2019 at the Princess Margaret Cancer Center in Toronto, Canada. He published in the areas of HCC, precision oncology, and has a great interest in sarcoma.